APRE
Aprea Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APRE Filings
Filing Date
Form Description
Form Type
2025-11-17
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-17 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-24
Form 8-K - Current report
Key Events
2025-10-24 · Key Events
Form 8-K - Current report
2025-10-15
Form 8-K - Current report
Key Events
2025-10-15 · Key Events
Form 8-K - Current report
2025-09-08
Form 8-K - Current report
Key Events
2025-09-08 · Key Events
Form 8-K - Current report
2025-08-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-12
Form 8-K - Current report
Key Events
2025-08-12 · Key Events
Form 8-K - Current report
2025-08-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
